Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study

Özge Aslan1, Ayşenur Oktay1, Fatih Eroğlu1

  • 1Ege University Faculty of Medicine, Department of Radiology, İzmir, Türkiye

Abstract

Insights

Magnetic resonance imaging (MRI) shows a low malignancy rate for Breast Imaging Reporting and Data System (BI-RADS) 3 lesions. Round shapes and irregular margins may indicate malignancy, necessitating individualized follow-up.

Area of Science:

  • Radiology and Imaging Science
  • Oncology
  • Breast Imaging

Background:

  • Breast Imaging Reporting and Data System (BI-RADS) 3 lesion categorization lacks clarity in magnetic resonance imaging (MRI) compared to mammography.
  • Increasing global MRI use leads to frequent incidental detection of BI-RADS 3 lesions, requiring further investigation.
  • Understanding the behavior and malignancy potential of MRI-detected BI-RADS 3 lesions is crucial for patient management.

Purpose of the Study:

  • To investigate the imaging characteristics of BI-RADS 3 lesions detected by MRI.
  • To analyze the follow-up results of these lesions.
  • To determine the malignancy rates of BI-RADS 3 lesions identified via MRI.

Main Methods:

  • Retrospective analysis of 216 breast MRI scans classified as BI-RADS 3 between January 2010 and January 2020.
  • Inclusion criteria: known biopsy/excision results or at least one year of radiological follow-up.
  • Assessment of patient age, cancer presence, follow-up intervals, and imaging findings; classification based on histopathology and follow-up.

Main Results:

  • Of the 216 lesions, 73% remained stable, 17.1% disappeared, 8% were excised, 1.4% enlarged, and 0.5% decreased in size.
  • The overall malignancy rate was 2.8%.
  • Round lesion shape, irregular margins, heterogeneous enhancement, and kinetic curve type 2 were significantly associated with malignancy.

Conclusions:

  • MRI-detected BI-RADS 3 lesions have a low malignancy rate, comparable to mammography and sonography.
  • Changes in lesion size, morphology, and enhancement patterns during follow-up are important indicators of potential malignancy.
  • Follow-up intervals for BI-RADS 3 lesions on MRI should be individualized based on lesion characteristics and clinical context.